Gen9 Garners $1,550,001 Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7a59f1d-0c41-43e5-a2b2-225dcd047919&Preview=1 - Date
9/9/2011 - Company Name
Gen9 - Mailing Address
500 Technology Sq. Cambridge, MA 01239 - Company Description
The company is developing synthetic biology technologies. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$1,550,001 - Transaction Round
Series B - Proceeds Purposes
Proceeds purposes were not disclosed. Amount reflects value of Series B Preferred Stock to be sold & Series B Preferred Stock underlying Warrants and Promissory Notes. Amount Sold reflects value of Preferred Stock sold. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
